+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

In-Vitro Fertilization Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 184 Pages
  • November 2025
  • Region: Global
  • 360iResearch™
  • ID: 4905019
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The IVF market is experiencing significant transformation as organizations adopt advanced technologies, respond to evolving patient needs, and navigate shifting regulations. Senior leaders are increasingly focused on balancing innovation, compliance, and operational efficiency to deliver reliable and scalable fertility care.

Market Snapshot: IVF Market Size and Trajectory

In 2024, the global in vitro fertilization (IVF) market achieved a value of USD 12.17 billion, with a projected compound annual growth rate (CAGR) of 10.72% through 2032. Market expansion is fueled by a steady increase in infertility rates worldwide and the growing use of assisted reproductive technologies. Investment in laboratory protocols, coupled with the adoption of digital infrastructure, is driving higher clinical standards in established and emerging markets. Enhanced clinical workflows and procedural consistency are enabling healthcare providers to deliver improved outcomes and streamline fertility services. Markets in both developed and emerging economies are adapting to a complex mix of regulatory conditions and patient demands, shaping the future of IVF offerings globally.

IVF Market Scope & Segmentation

  • Product: IVF culture media, disposable supplies, and laboratory equipment are critical to fertility programs, ensuring treatment reliability and supporting patient and provider trust throughout the care continuum.
  • Product Technologies: Advanced incubators, precision microscopes, imaging platforms, analyzers, cryopreservation technologies, lasers, ovum pumps, and digital witness tracking systems elevate laboratory efficiency, maintain data integrity, and help clinics adhere to regulatory guidelines.
  • Embryo Source: IVF solutions using both fresh and frozen embryos, sourced from patients and donors, offer flexibility and suitability for different clinical scenarios and diverse patient populations.
  • Procedure Type: Services span conventional IVF, intracytoplasmic sperm injection (ICSI), assisted hatching, transfers using frozen or zygote intrafallopian methods, and gamete transfers, enabling tailored approaches to a range of infertility causes.
  • Application: IVF addresses a wide spectrum of reproductive health needs, including tubal and ovulatory disorders and male infertility, adapting to various treatment complexities and demographic profiles.
  • End User: Clinics, ambulatory surgery centers, and hospitals tailor IVF offerings to fit their operational frameworks, aligning patient engagement strategies and resource allocation with treatment demands.
  • Region: The Americas, Europe, Middle East, Africa, and Asia-Pacific markets each demonstrate unique regulatory, clinical, and investment characteristics. Notably, the Asia-Pacific region stands out for rapid technology adoption and evolving service offerings, shaped by local policies and funding trends.
  • Company Coverage: Influential industry participants include Carl Zeiss AG, Cook Medical Inc., CooperSurgical Inc., Corning Incorporated, Ferring B.V., Esco Micro Pte. Ltd., FertiPro N.V., Genea Biomedx Pty Ltd., Hamilton Thorne, Inc., INVO Bioscience, Inc., IVFtech ApS, Kitazato Corporation, Laboratoire CCD, Merck KGaA, Nidacon International AB, Nikon Corporation, Olympus Corporation, Thermo Fisher Scientific Inc., Vitrolife AB, and Meiji Techno Co., Ltd.

Key Strategic Takeaways for Senior Decision-Makers

  • AI and automation tools improve operational transparency and support quality assurance goals in IVF laboratories, enabling clinics to achieve consistency and enhance clinical reliability.
  • Telehealth and remote monitoring expand patient access to fertility care, bridge geographic gaps, and create opportunities to reach individuals in underserved communities.
  • Enhanced collaboration between clinics and suppliers streamlines procurement processes and allows for rapid adaptation to changing clinical and logistical requirements.
  • Selective investments in clinical infrastructure help broaden patient access to advanced reproductive technologies and position organizations for scalable growth as demand evolves.
  • Strict adherence to international regulatory frameworks supports operational consistency and enables expansion into new jurisdictions for organizations with cross-border ambitions.
  • Strategic supplier management increases resilience to market and regulatory disruption, reducing reliance on single sources and supporting uninterrupted service delivery.

Tariff Impact on Procurement and Supply Chain Strategy

Forthcoming U.S. tariff changes set for 2025 have prompted IVF organizations to diversify supplier networks and strengthen partnerships with regional manufacturers. Many clinics and suppliers are revising agreements to safeguard operational continuity and mitigate potential impacts from variable international trade conditions.

Methodology & Data Sources

This assessment is based on secondary research, consultations with clinical and procurement experts, and contributions from regulatory professionals. Patent landscape reviews, current sector trends, and academic research underpin the findings and market perspectives included here.

Why This Report Matters

  • Enables senior decision-makers to benchmark and refine operational strategies, ensuring alignment with evolving IVF market requirements.
  • Supports robust planning in procurement, compliance, and risk management for organizations engaging in international fertility care delivery.
  • Clarifies how technology integration and changes in regulation are reshaping organizational approaches to risk mitigation and competitive positioning.

Conclusion

Leaders can leverage these insights to guide teams, optimize resources, and steer organizational direction in the rapidly evolving IVF sector. This analysis provides support for decisions that drive sustainable growth.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Increasing use of AI-driven embryo selection and time-lapse imaging in IVF labs to optimize implantation rates
5.2. Rapid growth in elective egg freezing services fueled by workplace fertility benefits and social trends
5.3. Expansion of oncofertility programs for cancer patients seeking fertility preservation before treatment
5.4. Emergence of portable point-of-care IVF systems enabling decentralized fertility treatments in emerging markets
5.5. Rising implementation of PGT-A testing services to reduce genetic abnormalities and improve outcomes
5.6. Integration of telemedicine and digital health platforms for remote IVF consultations and monitoring
5.7. Increasing collaboration between fertility clinics and genetic testing labs for personalized embryo assessment
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. In-Vitro Fertilization Market, by Product
8.1. Culture Media
8.1.1. Cryopreservation Media
8.1.2. Embryo Culture Media
8.1.3. Ovum Processing Media
8.1.4. Sperm Processing Media
8.2. Disposable Devices & accessories
8.3. Equipment
8.3.1. Anti-vibration Tables
8.3.2. Cryosystems
8.3.3. Gas Analyzers
8.3.4. Imaging Systems
8.3.5. Incubators
8.3.6. IVF Cabinets
8.3.7. Laser Systems
8.3.8. Micromanipulator Systems
8.3.9. Microscopes
8.3.10. Ovum Aspiration Pumps
8.3.11. Sperm Analyzer Systems
8.3.12. Sperm Separation Devices
8.3.13. Witness Systems
9. In-Vitro Fertilization Market, by Embryo Source
9.1. Fresh Donor
9.2. Fresh Non-donor
9.3. Frozen Donor
9.4. Frozen Non-donor
10. In-Vitro Fertilization Market, by Procedure Type
10.1. Assisted Hatching
10.2. Conventional IVF
10.3. Frozen Embryo Transfer (FET)
10.4. Gamete Intrafallopian Transfer (GIFT)
10.5. Intracytoplasmic Sperm Injection (ICSI)
10.6. Zygote Intrafallopian Transfer (ZIFT)
11. In-Vitro Fertilization Market, by Application
11.1. Female Infertility
11.1.1. Endometriosis
11.1.2. Ovulatory Disorders
11.1.3. Tubal Factor Infertility
11.1.4. Unexplained Infertility
11.2. Male Infertility
11.2.1. Abnormal Sperm Morphology
11.2.2. Low Sperm Count
11.2.3. Poor Sperm Motility
12. In-Vitro Fertilization Market, by End User
12.1. Ambulatory Surgery Centers
12.2. Fertility Clinics
12.3. Hospitals
13. In-Vitro Fertilization Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. In-Vitro Fertilization Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. In-Vitro Fertilization Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Carl Zeiss AG
16.3.2. Cook Medical Inc.
16.3.3. CooperSurgical Inc.
16.3.4. Corning incorporated
16.3.5. Ferring B.V.
16.3.6. Esco micro pte. Ltd.
16.3.7. FertiPro N.V.
16.3.8. Genea Biomedx Pty Ltd.
16.3.9. Hamilton Thorne, Inc.
16.3.10. INVO Bioscience, Inc.
16.3.11. IVFtech ApS
16.3.12. Kitazato Corporation
16.3.13. Laboratoire CCD
16.3.14. Merck KGaA
16.3.15. Nidacon International AB
16.3.16. Nikon Corporation
16.3.17. Olympus Corporation
16.3.18. Thermo Fisher Scientific Inc.
16.3.19. Vitrolife AB
16.3.20. Meiji Techno Co., Ltd.

Companies Mentioned

The companies profiled in this In-Vitro Fertilization market report include:
  • Carl Zeiss AG
  • Cook Medical Inc.
  • CooperSurgical Inc.
  • Corning incorporated
  • Ferring B.V.
  • Esco micro pte. Ltd.
  • FertiPro N.V.
  • Genea Biomedx Pty Ltd.
  • Hamilton Thorne, Inc.
  • INVO Bioscience, Inc.
  • IVFtech ApS
  • Kitazato Corporation
  • Laboratoire CCD
  • Merck KGaA
  • Nidacon International AB
  • Nikon Corporation
  • Olympus Corporation
  • Thermo Fisher Scientific Inc.
  • Vitrolife AB
  • Meiji Techno Co., Ltd.

Table Information